Fresenius Medical Care AG (FMCQF) Cash & Equivalents (2009 - 2025)

Fresenius Medical Care AG (FMCQF) has 17 years of Cash & Equivalents data on file, last reported at $1.9 billion in Q4 2025.

• In Q4 2025, Cash & Equivalents rose 47.61% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (up 47.61% YoY), while the FY2025 annual figure was $1.9 billion, up 47.61% from the prior year.
• Cash & Equivalents climbed to $1.9 billion in Q4 2025, from $1.5 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.9 billion in Q2 2025 and bottomed at $1.1 billion in Q1 2025.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2022 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 47.61% in 2025, down 27.34% in 2025.
• Year by year, Cash & Equivalents stood at $1.7 billion in 2021, then dropped by 23.33% to $1.3 billion in 2022, then climbed by 18.16% to $1.5 billion in 2023, then slipped by 17.89% to $1.3 billion in 2024, then surged by 47.61% to $1.9 billion in 2025.
• The last three Cash & Equivalents figures came in at $1.9 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.9 billion (Q2 2025), per Business Quant data.

Peer Comparison